Total Payments
$503,728
2024 Payments
$81,771
Companies
43
Transactions
769
Medicare Patients
6,066
Medicare Billing
$1.1M
Payment Breakdown by Category
Education$363,909 (72.2%)
Other$93,600 (18.6%)
Travel$24,022 (4.8%)
Food & Beverage$22,038 (4.4%)
Gifts$158.96 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $363,909 | 161 | 72.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $93,600 | 48 | 18.6% |
| Travel and Lodging | $24,022 | 90 | 4.8% |
| Food and Beverage | $22,038 | 468 | 4.4% |
| Gift | $158.96 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $494,920 | 406 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,735 | 77 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,015 | 40 | $0 (2023) |
| GlaxoSmithKline, LLC. | $988.51 | 62 | $0 (2024) |
| Ethicon Inc. | $816.30 | 3 | $0 (2020) |
| Mylan Specialty L.P. | $542.07 | 26 | $0 (2024) |
| GENZYME CORPORATION | $475.31 | 21 | $0 (2024) |
| Genentech USA, Inc. | $416.47 | 24 | $0 (2024) |
| Celgene Corporation | $309.75 | 6 | $0 (2019) |
| Galvanize Therapeutics, Inc | $253.47 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $81,771 | 111 | INTUITIVE SURGICAL, INC. ($80,416) |
| 2023 | $126,212 | 157 | Intuitive Surgical, Inc. ($124,729) |
| 2022 | $190,697 | 219 | Intuitive Surgical, Inc. ($189,136) |
| 2021 | $97,442 | 112 | Intuitive Surgical, Inc. ($96,942) |
| 2020 | $334.21 | 16 | GlaxoSmithKline, LLC. ($77.88) |
| 2019 | $3,876 | 57 | Intuitive Surgical, Inc. ($2,079) |
| 2018 | $2,749 | 62 | Intuitive Surgical, Inc. ($1,605) |
| 2017 | $647.61 | 35 | Genentech USA, Inc. ($151.58) |
All Payment Transactions
769 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: RESPIRATORY | ||||||
| 12/27/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $2,000.00 | General |
| Category: SURGERY | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: Immunology | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $2,000.00 | General |
| Category: SURGERY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.20 | General |
| Category: Immunology | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $6.00 | General |
| Category: SURGERY | ||||||
| 11/13/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $2,000.00 | General |
| Category: SURGERY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 10/30/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/25/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $2,000.00 | General |
| Category: SURGERY | ||||||
| 10/16/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: SURGERY | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $1,000.00 | General |
| Category: SURGERY | ||||||
| 10/09/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $2,000.00 | General |
| Category: SURGERY | ||||||
| 10/02/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 10/02/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $2,000.00 | General |
| Category: SURGERY | ||||||
| 10/02/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $300.00 | General |
| Category: SURGERY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,804 | 3,231 | $610,900 | $321,418 |
| 2022 | 20 | 1,518 | 2,762 | $503,395 | $272,575 |
| 2021 | 14 | 1,347 | 2,646 | $472,315 | $270,427 |
| 2020 | 22 | 1,397 | 2,662 | $470,570 | $264,624 |
Total Patients
6,066
Total Services
11,301
Medicare Billing
$1.1M
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 149 | 668 | $216,775 | $119,017 | 54.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 409 | 707 | $120,190 | $73,692 | 61.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 137 | 379 | $54,655 | $37,764 | 69.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 458 | 729 | $58,320 | $16,420 | 28.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 77 | 84 | $20,160 | $12,486 | 61.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 51 | 51 | $16,575 | $9,467 | 57.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $16,560 | $9,367 | 56.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 64 | $17,280 | $9,292 | 53.8% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 38 | 38 | $24,700 | $5,443 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 80 | $9,600 | $5,299 | 55.2% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 21 | 21 | $6,300 | $3,635 | 57.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 41 | 41 | $6,970 | $3,344 | 48.0% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2023 | 51 | 53 | $5,300 | $2,909 | 54.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 41 | $3,895 | $2,716 | 69.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 14 | 41 | $6,560 | $2,321 | 35.4% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 16 | 16 | $6,800 | $1,942 | 28.6% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 12 | 12 | $6,600 | $1,770 | 26.8% |
| 31622 | Diagnostic exam of lung airway using an endoscope | Facility | 2023 | 15 | 15 | $6,000 | $1,641 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $2,090 | $1,200 | 57.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 56 | 58 | $4,060 | $611.32 | 15.1% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 23 | 35 | $700.00 | $547.75 | 78.3% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 13 | 18 | $810.00 | $536.22 | 66.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 172 | 529 | $171,925 | $97,452 | 56.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 344 | 575 | $97,750 | $58,006 | 59.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 137 | 502 | $62,750 | $43,429 | 69.2% |
About Dr. Thomas Meyer, M.D
Dr. Thomas Meyer, M.D is a Pulmonary Disease healthcare provider based in Wynnewood, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700812641.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Meyer, M.D has received a total of $503,728 in payments from pharmaceutical and medical device companies, with $81,771 received in 2024. These payments were reported across 769 transactions from 43 companies. The most common payment nature is "Education" ($363,909).
As a Medicare-enrolled provider, Meyer has provided services to 6,066 Medicare beneficiaries, totaling 11,301 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Wynnewood, PA
- Active Since 06/23/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1700812641
Products in Payments
- Da Vinci Surgical System (Device) $472,270
- DA VINCI SP (Device) $21,650
- ION (Device) $1,000
- MONARCH (Device) $759.89
- FASENRA (Biological) $708.43
- DUPIXENT (Biological) $650.30
- OFEV (Drug) $583.12
- TRELEGY ELLIPTA (Drug) $558.62
- NUCALA (Biological) $308.93
- Xolair (Biological) $267.68
- SYMBICORT (Drug) $265.23
- ALIYA SYSTEM (Device) $253.47
- BREZTRI (Drug) $253.47
- Yupelri (Drug) $239.42
- Arikayce (Drug) $234.09
- YUPELRI (Drug) $228.48
- ACTHAR (Biological) $205.97
- STIOLTO RESPIMAT (Drug) $201.16
- PURIFIED CORTROPHIN GEL (Drug) $187.18
- BEVESPI AEROSPHERE (Drug) $181.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Wynnewood
Jacqueline Sutter, D.o, D.O
Pulmonary Disease — Payments: $184,280
Pulmonary Disease $184,280
Dr. Robert Promisloff, D.o, D.O
Pulmonary Disease — Payments: $73,450
Pulmonary Disease $73,450
Rochelle Goldberg, Md, MD
Pulmonary Disease — Payments: $12,384
Pulmonary Disease $12,384
Lauren Rome, M.d, M.D
Pulmonary Disease — Payments: $12,115
Pulmonary Disease $12,115
Dr. Gregory Lenchner, M.d, M.D
Pulmonary Disease — Payments: $11,762
Pulmonary Disease $11,762
Catherine Kuntz, M.d, M.D
Pulmonary Disease — Payments: $7,462
Pulmonary Disease $7,462